AnalystsRobert WassermanRobert Wasserman's Stock Forecasts
AnalystsRobert Wasserman
Analyst Ranking
Bottom 7%
#4261 out of 4548 analysts
Average Return
-6.61%
Win Rate
40%24 out of 60
Risk vs Reward
Poor
Good
Robert Wasserman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Molekule Group IncMKULQ | +174.00% | $5.00 | $13.70 | 2022-01-31 - 2022-06-14 | Buy |
Ligand Pharmaceuticals IncLGND | +119.54% | $92.48 | $203.03 | 2020-02-05 - 2021-02-05 | Strong Buy |
Halozyme Therapeutics IncHALO | +69.20% | $27.40 | $46.36 | 2020-06-30 - 2021-07-01 | Strong Buy |
Intensity Therapeutics IncINTS | +59.77% | $2.61 | $4.17 | 2023-11-13 - 2024-04-15 | Buy |
Bio Techne CorpTECH | +53.17% | $65.51 | $100.34 | 2020-05-13 - 2021-05-14 | Strong Buy |
Robert Wasserman Analyst Color
Get additional color on Robert Wasserman's coverage of popular stocks
Robert Wasserman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ligand Pharmaceuticals IncLGND | 6 | Strong Buy | $95.00 | +19.09% | Reiterates | 4 days ago |
Emergent Biosolutions IncEBS | 8 | Strong Buy | $5.00 | +152.53% | Reiterates | 5 days ago |
Integer Holdings CorpITGR | 3 | Strong Buy | $130.00 | +9.57% | Maintains | 19 days ago |
Omniab IncOABI | 4 | Strong Buy | $8.00 | +61.62% | Reiterates | 25 days ago |
Intensity Therapeutics IncINTS | 4 | Buy | $12.00 | +187.77% | Reiterates | a month ago |
Immunoprecise Antibodies LtdIPA | 4 | Buy | $5.00 | +303.23% | Reiterates | a month ago |
Nephros IncNEPH | 1 | Buy | $5.00 | +150.00% | Upgrades | a month ago |
Alterity Therapeutics LtdATHE | 1 | Buy | $4.00 | +63.27% | Reiterates | a month ago |
Processa Pharmaceuticals IncPCSA | 1 | Buy | $4.00 | +164.03% | Reiterates | a month ago |
Codexis IncCDXS | 3 | Strong Buy | $9.00 | +234.57% | Upgrades | 2 months ago |
Halozyme Therapeutics IncHALO | 4 | Strong Buy | $50.00 | +29.13% | Reiterates | 3 months ago |
Anebulo Pharmaceuticals IncANEB | 4 | Buy | $8.00 | +170.36% | Reiterates | 6 months ago |
Abcellera Biologics IncABCL | 2 | Strong Buy | $12.00 | +187.08% | Maintains | 8 months ago |
Bio Techne CorpTECH | 3 | Strong Buy | $120.00 | +83.15% | Reiterates | 8 months ago |
Proto Labs IncPRLB | 5 | Strong Buy | $45.00 | +41.46% | Reiterates | a year ago |
Molekule Group IncMKULQ | 4 | Buy | $7.00 | +12,862.96% | Reiterates | a year ago |
Fortress Biotech IncFBIO | 1 | Buy | $75.00 | N/A | Reiterates | a year ago |
Repligen CorpRGEN | 1 | Strong Buy | $230.00 | N/A | Initiates Coverage On | a year ago |
Danaher CorpDHR | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Thermo Fisher Scientific IncTMO | 1 | Strong Buy | $580.00 | N/A | Initiates Coverage On | 3 years ago |
Biolife Solutions IncBLFS | 2 | Strong Buy | $54.00 | N/A | Upgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.